Dr. Mads Daugaard is the Head of the Molecular Pathology and Cell Imaging Unit and a Senior Research Scientist at the Vancouver Prostate Centre, as well as an associate professor at the University of British Columbia. Daugaard co-founded several companies, including VAR2 Pharmaceuticals and Rakovina Therapeutics, and has played a crucial role in advancing translational cancer research. They have received notable accolades, including the Robert J. Arceci Innovation Award and the Prostate Cancer Canada Rising Star Award. With expertise in molecular biology and cancer diagnostics, Daugaard continues to lead innovative research in high-risk adult and childhood solid tumors.
This person is not in the org chart
This person is not in any teams
This person is not in any offices